Wednesday, August 04, 2021 11:11:29 AM
Recent BNTX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 12:41:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2024 08:15:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/10/2024 08:13:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:02:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/08/2024 08:24:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/04/2024 08:17:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 09:14:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 10:18:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 08:18:29 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/01/2024 12:12:03 PM
- BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day • GlobeNewswire Inc. • 10/01/2024 10:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/30/2024 08:52:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/27/2024 09:12:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/25/2024 11:14:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2024 01:17:40 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • Business Wire • 09/20/2024 12:11:00 PM
- Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union • GlobeNewswire Inc. • 09/20/2024 12:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 11:28:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:14:09 PM
- BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 • GlobeNewswire Inc. • 09/17/2024 10:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:35:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 08:12:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:12:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 12:53:58 PM
- BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 • GlobeNewswire Inc. • 09/05/2024 11:15:00 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • BURU • Oct 15, 2024 8:21 AM